SKI Market

A+| A| A-|

Indian Indices

Sensex

74,955.98 396.74
( 0.53%)

Global Indices

Nasdaq

49,785.17 59.69
(0.12%)

Dow Jones

7,421.51 -12.33
(-0.17%)

Hang Seng

63,198.64 456.07
(0.73%)

Nikkei 225

10,253.59 -15.84
(-0.15%)

Forex

USD-INR

95.14 0.72
(0.77%)

EUR-INR

111.99 0.76
(0.69%)

GBP-INR

129.47 0.85
(0.66%)

JPY-INR

0.61 0.00
(0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5510998

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

22.85

106009.78

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.63

Date	Headline
29-Apr-2026	OneSource's partner Dr. Reddy's receives Health Canada approval for Semaglutide Injection
23-Apr-2026	Shree Ganesh Remedies Ltd Spikes 3.78%
06-Mar-2026	Dr Reddy's Lab gets EIR from USFDA for Srikakulam facility
19-Feb-2026	Dr. Reddy’s Labs acquires 'Progynova' portfolio from UK's Mercury Pharma Group
19-Feb-2026	Nifty drops below 25,650 mark; auto shares snap 2-day gains
22-Jan-2026	Dr Reddy’s Lab Q3 PAT drops 14% YoY to Rs 1,210 cr
21-Jan-2026	Dr Reddy's Laboratories consolidated net profit declines 14.42% in the December 2025 quarter
01-Jan-2026	Dr Reddy’s Swiss subsidiary gets USFDA CRL for biosimilar AVT03
24-Dec-2025	Dr Reddys Laboratories to announce Quarterly Result
09-Dec-2025	Dr Reddys Laboratories allots 9,165 equity shares under ESOS

<< < 1 2 > >>

74,955.98 396.74 ( 0.53%)

49,785.17 59.69 (0.12%)

7,421.51 -12.33 (-0.17%)

63,198.64 456.07 (0.73%)

10,253.59 -15.84 (-0.15%)

95.14 0.72 (0.77%)

111.99 0.76 (0.69%)

129.47 0.85 (0.66%)

0.61 0.00 (0.51%)